Bryan Johnson Blueprint Longevity Research Compounds | QSC
BLUEPRINT PROTOCOL · RESEARCH COMPOUNDS
Bryan Johnson Blueprint Protocol Compounds Research-grade longevity peptides at QSC — NAD+, Epitalon, MOTS-c, SS-31, FOXO4-DRI, GHK-Cu and more
Researchers studying the longevity compounds discussed in Bryan Johnson’s Blueprint protocol can access research-grade verified versions at QSC — ≥99% HPLC purity, Janoshik independent COA, US domestic 2–4 day delivery. All for in vitro laboratory research only.
Bryan Johnson is a biohacking entrepreneur and longevity researcher who publicly documents his Blueprint protocol. QSC is a research compound supplier — we provide research-grade peptides and longevity compounds for in vitro laboratory research. This page is for researchers studying the biological mechanisms behind compounds discussed in Bryan Johnson’s public protocol. QSC is not affiliated with Bryan Johnson or Blueprint. All compounds sold for research only.
What compounds does Bryan Johnson’s Blueprint protocol include?
Bryan Johnson’s Blueprint longevity protocol has publicly included a range of compounds that overlap with QSC’s research catalog: NAD+ precursors (NMN/NR for sirtuin activation), metformin (glucose metabolism), rapamycin (mTOR inhibition), DHEA, lithium (low-dose neuroprotection), and various peptides and longevity compounds. Johnson documents his protocol publicly through blueprint.bryanjohnson.co. QSC provides research-grade versions of longevity compounds including NAD+, Epitalon, MOTS-c, SS-31, FOXO4-DRI, Humanin, Pinealon, and GHK-Cu for in vitro laboratory research.
What longevity peptides does Bryan Johnson take?
Bryan Johnson has publicly discussed using compounds from multiple longevity categories. The peptides most aligned with his documented protocol and publicly available through QSC for research include: NAD+ (sirtuin/PARP substrate, declinesage-dependently — Johnson documents NAD+ supplementation), Epitalon (telomerase activator, Khavinson peptide, longevity research), MOTS-c (mitochondrial-derived peptide, AMPK activation), SS-31/Elamipretide (cardiolipin-targeted mitochondrial peptide), FOXO4-DRI (senolytic — senescent cell clearance), GHK-Cu (tissue regeneration, copper peptide), and Humanin (FPRL2/gp130 neuroprotection). All available at QSC for in vitro research.
Where can I research the compounds Bryan Johnson uses?
QSC (qscpeptide.com) provides research-grade versions of many longevity compounds discussed in Bryan Johnson’s Blueprint protocol — including NAD+, Epitalon, MOTS-c, SS-31, FOXO4-DRI, GHK-Cu, Humanin, Pinealon, Sermorelin, and Ipamorelin — at ≥99% HPLC purity with Janoshik independent COA. QSC’s research library includes dedicated research hubs for each compound with mechanism of action, clinical trial data, and comparative analyses. All for in vitro laboratory research only.
What is Bryan Johnson’s Blueprint protocol?
Bryan Johnson’s Blueprint is a self-documented longevity protocol in which Johnson, a tech entrepreneur, follows a rigorously measured anti-aging regimen with the stated goal of reversing biological aging markers. The protocol has been publicly documented at blueprint.bryanjohnson.co and includes diet, exercise, sleep optimisation, and a large stack of compounds. Researchers interested in the compounds discussed in Blueprint can access research-grade versions at QSC for in vitro study.
Does QSC stock NAD+ discussed in Bryan Johnson’s protocol?
Yes — QSC stocks research-grade NAD+ (nicotinamide adenine dinucleotide) at ≥99% HPLC purity with Janoshik independent COA. NAD+ is the core coenzyme substrate for sirtuins (SIRT1–7) and PARPs — the longevity pathways central to the Blueprint protocol’s anti-aging rationale. NAD+ declines 40–60% with aging. QSC also stocks MOTS-c (AMPK activator, the mitochondria-derived peptide that works synergistically with NAD+ biology) and Epitalon (telomerase activator). All for in vitro laboratory research.
Does QSC stock GHK-Cu and Epitalon discussed in longevity research?
Yes — QSC stocks both GHK-Cu (glycine-histidine-lysine copper peptide, tissue regeneration/collagen/MMP modulation) and Epitalon (Ala-Glu-Asp-Gly tetrapeptide, hTERT telomerase activation, Khavinson longevity research) at ≥99% HPLC purity with Janoshik independent COA. Both appear frequently in longevity research discussions and biohacking content. QSC also stocks Pinealon (complementary Khavinson epigenetic bioregulator) and FOXO4-DRI (senolytic peptide, Nature 2017 data). All for in vitro research only.
Research the Blueprint Longevity Compounds — at QSC
Research Use Only: All products on qscpeptide.com are sold strictly for in vitro laboratory research purposes only. Not for human or veterinary use. QSC is not affiliated with Bryan Johnson or Blueprint. This page is independent informational content for researchers.
